Jump to navigation
The ‘Quit Smoking Study’ will test how well e-cigarettes can help people quit smoking, when compared with nicotine lozenges or gum.
This project will be the first to assess the types, severity, and individual and contextual correlates of harms from others’ heavy drinking in a wide range of societies with greatly varying drinking cultures and policies.
This is the PhD project of Ms Shann Hulme.
This is the PhD project of Vivienne Moxham-Hall (supervised by Professor Alison Ritter and Dr Caitlin Hughes) investigating the utility of indexes
This study will investigate the first online alcohol and substance use prevention program targeted at both students and their parents.
AOD use has a negative impact on workplaces and may result in accidents, injuries, reduced productivity, abstenteesim, poor work relationships and
NDRI researchers will be collaborating with others to update the social and economic costs of smoking in Australia.
Tapentadol is a centrally acting opioid analgesic with dual mechanisms of action, specifically µ-opioid receptor agonist and noradrenaline reuptake
The majority of smokers want to quit smoking but stopping is hard.
This study will evaluate an evidence based approach to the design of a new treatment service for users of methamphetamine.
This project will investigate the feasibility of delivering routine alcohol screening and brief intervention in hospital emergency departments and emergency short stay units.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Monday 20 September 2021